Bank of the West’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $355K | Sell |
1,229
-38
| -3% | -$11K | 0.04% | 187 |
|
|
2022
Q3 | $367K | Buy |
1,267
+41
| +3% | +$11.9K | 0.05% | 174 |
|
|
2022
Q2 | $345K | Sell |
1,226
-34
| -3% | -$9.57K | 0.04% | 181 |
|
|
2022
Q1 | $329K | Sell |
1,260
-38
| -3% | -$9.92K | 0.03% | 188 |
|
|
2021
Q4 | $285K | Sell |
1,298
-269
| -17% | -$59.1K | 0.03% | 204 |
|
|
2021
Q3 | $284K | Sell |
1,567
-61
| -4% | -$11.1K | 0.03% | 202 |
|
|
2021
Q2 | $328K | Sell |
1,628
-2,506
| -61% | -$505K | 0.03% | 193 |
|
|
2021
Q1 | $888K | Sell |
4,134
-324
| -7% | -$69.6K | 0.1% | 134 |
|
|
2020
Q4 | $1.05M | Buy |
4,458
+90
| +2% | +$21.3K | 0.12% | 122 |
|
|
2020
Q3 | $1.19M | Sell |
4,368
-2,216
| -34% | -$603K | 0.16% | 108 |
|
|
2020
Q2 | $1.91M | Sell |
6,584
-319
| -5% | -$92.6K | 0.26% | 88 |
|
|
2020
Q1 | $1.64M | Sell |
6,903
-1,012
| -13% | -$241K | 0.26% | 94 |
|
|
2019
Q4 | $1.73M | Sell |
7,915
-63
| -0.8% | -$13.8K | 0.2% | 107 |
|
|
2019
Q3 | $1.35M | Buy |
7,978
+340
| +4% | +$57.6K | 0.16% | 121 |
|
|
2019
Q2 | $1.4M | Sell |
7,638
-12
| -0.2% | -$2.2K | 0.16% | 126 |
|
|
2019
Q1 | $1.41M | Sell |
7,650
-11,064
| -59% | -$2.03M | 0.16% | 131 |
|
|
2018
Q4 | $3.36M | Buy |
18,714
+9,226
| +97% | +$1.66M | 0.4% | 73 |
|
|
2018
Q3 | $1.83M | Buy |
9,488
+596
| +7% | +$115K | 0.21% | 119 |
|
|
2018
Q2 | $1.51M | Buy |
8,892
+792
| +10% | +$135K | 0.19% | 136 |
|
|
2018
Q1 | $1.32M | Buy |
8,100
+1,304
| +19% | +$213K | 0.17% | 150 |
|
|
2017
Q4 | $1.02M | Buy |
+6,796
| New | +$1.02M | 0.13% | 156 |
|